Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 56Thoracic 3Gastrointestinal 3Myeloid 1Head & Neck 1Gynecologic 1Breast 1

Conditions

Myeloproliferative Disorders 3Multiple Myeloma 2Lymphoma, Extranodal NK-T-Cell 2Lymphohistiocytosis, Hemophagocytic 2Lung Neoplasms 2Leukemia 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Thyroid Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Histiocytosis 1Glioblastoma 1Endometrial Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Brain Neoplasms 1

Interventions

Bevacizumab 2temsirolimus 1Valproic Acid 1Sirolimus 1Immunoglobulin G 1Gemcitabine 1Disulfides 1Cetuximab 1Carboplatin 1Antineoplastic Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Transitional Cell × Gemcitabine × Myeloid × Clear all
NCT00588666 2016-01-22

Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
51 enrolled 7 charts
GenitourinaryMyeloid

Carcinoma, Transitional Cell, Myeloproliferative Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡